SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031373
Filing Date
2022-11-10
Accepted
2022-11-10 16:26:02
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1030178
2 ex31-1.htm EX-31.1 12092
3 ex31-2.htm EX-31.2 8532
4 ex32-1.htm EX-32.1 6141
  Complete submission text file 0001493152-22-031373.txt   5218368

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eton-20220930.xsd EX-101.SCH 37699
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eton-20220930_cal.xml EX-101.CAL 49707
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eton-20220930_def.xml EX-101.DEF 192601
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eton-20220930_lab.xml EX-101.LAB 366101
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eton-20220930_pre.xml EX-101.PRE 275078
53 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 724857
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 221377675
SIC: 2834 Pharmaceutical Preparations